These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 27362551)

  • 21. Transarterial Chemoembolization Followed by Radiofrequency Ablation for Hepatocellular Carcinoma: Impact of the Time Interval between the Two Treatments on Outcome.
    Liu D; Liu M; Su L; Wang Y; Zhang X; Long H; Kuang M; Xie X; Lin M
    J Vasc Interv Radiol; 2019 Dec; 30(12):1879-1886. PubMed ID: 31669087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequential Use of Transhepatic Arterial Chemoembolization and Bipolar Radiofrequency Ablation in the Clinical Therapy of Hepatocellular Carcinoma.
    Liang HY; Guo QY; Sun W; Mao XN; Wen F; Shan M; Zhao G; Wang XH; Lu ZM
    Cancer Biother Radiopharm; 2015 Dec; 30(10):427-32. PubMed ID: 26683133
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New approach for hepatocellular carcinoma treatment.
    Tabacelia D; Stroescu C; Dumitru R; Grigorescu RR; Martiniuc A; Husar-Sburlan IA; Copca N
    J Med Life; 2022 Jan; 15(1):138-143. PubMed ID: 35186148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transarterial Chemoembolization versus Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma after Resection within Barcelona Clinic Liver Cancer Stage 0/A: A Retrospective Comparative Study.
    Chen R; Gan Y; Ge N; Chen Y; Wang Y; Zhang B; Wang Y; Ye S; Ren Z
    J Vasc Interv Radiol; 2016 Dec; 27(12):1829-1836. PubMed ID: 27553917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma in patients with chronic liver disease: a randomised controlled phase 2 trial.
    Vietti Violi N; Duran R; Guiu B; Cercueil JP; Aubé C; Digklia A; Pache I; Deltenre P; Knebel JF; Denys A
    Lancet Gastroenterol Hepatol; 2018 May; 3(5):317-325. PubMed ID: 29503247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma.
    Xu Z; Xie H; Zhou L; Chen X; Zheng S
    Anal Cell Pathol (Amst); 2019; 2019():8619096. PubMed ID: 31534899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single-session combined therapy with chemoembolization and radiofrequency ablation in hepatocellular carcinoma less than or equal to 5 cm: a preliminary study.
    Kang SG; Yoon CJ; Jeong SH; Kim JW; Lee SH; Lee KH; Kim YH
    J Vasc Interv Radiol; 2009 Dec; 20(12):1570-7. PubMed ID: 19879777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early Stage Hepatocellular Carcinomas Not Feasible for Ultrasound-Guided Radiofrequency Ablation: Comparison of Transarterial Chemoembolization Alone and Combined Therapy with Transarterial Chemoembolization and Radiofrequency Ablation.
    Hyun D; Cho SK; Shin SW; Park KB; Park HS; Choo SW; Do YS; Choo IW; Lee MW; Rhim H; Lim HK
    Cardiovasc Intervent Radiol; 2016 Mar; 39(3):417-25. PubMed ID: 26246215
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors].
    Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP
    Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transarterial chemoembolization plus computed tomography-guided percutaneous radiofrequency ablation for small hepatocellular carcinoma in special locations].
    Guo YJ; Huang WS; Zhou B; Chen JW; Cai MY; Qian JS; Huang MS; Shan H; Zhu KS
    Zhonghua Yi Xue Za Zhi; 2013 Sep; 93(33):2627-30. PubMed ID: 24360041
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study.
    Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E
    Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC.
    Iezzi R; Posa A; Tanzilli A; Carchesio F; Pompili M; Manfredi R
    Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypertonic saline-enhanced radiofrequency versus chemoembolization sequential radiofrequency in the treatment of large hepatocellular carcinoma.
    El-Kady NM; Esmat G; Mahmoud EH; Darweesh SK; Mahmoud SH; Elagawy WA
    Eur J Gastroenterol Hepatol; 2013 May; 25(5):628-33. PubMed ID: 23325283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Small hepatocellular carcinoma: is radiofrequency ablation combined with transcatheter arterial chemoembolization more effective than radiofrequency ablation alone for treatment?
    Shibata T; Isoda H; Hirokawa Y; Arizono S; Shimada K; Togashi K
    Radiology; 2009 Sep; 252(3):905-13. PubMed ID: 19567647
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radiofrequency ablation in the treatment of small hepatocellular carcinomas: comparison of the radiofrequency effect with and without chemoembolization.
    Kitamoto M; Imagawa M; Yamada H; Watanabe C; Sumioka M; Satoh O; Shimamoto M; Kodama M; Kimura S; Kishimoto K; Okamoto Y; Fukuda Y; Dohi K
    AJR Am J Roentgenol; 2003 Oct; 181(4):997-1003. PubMed ID: 14500217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventional oncology treatments for unresectable early stage HCC in patients with a high risk for intraprocedural bleeding: Is a single-step combined therapy safe and feasible?
    Iezzi R; Pompili M; Posa A; Carchesio F; Siciliano M; Annicchiarico BE; Agnes S; Giuliante F; Garcovich M; Cerrito L; Ponziani FR; Basso M; Cassano A; Rapaccini GL; De Gaetano AM; Gasbarrini A; Manfredi R;
    Eur J Radiol; 2019 May; 114():32-37. PubMed ID: 31005173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified cisplatin-based transcatheter arterial chemoembolization for large hepatocellular carcinoma: multivariate analysis of predictive factors for tumor response and survival in a 163-patient cohort.
    Yoon HM; Kim JH; Kim EJ; Gwon DI; Ko GY; Ko HK
    J Vasc Interv Radiol; 2013 Nov; 24(11):1639-46. PubMed ID: 23962438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microwave ablation for hepatocellular carcinoma associated with Budd-Chiari syndrome after transarterial chemoembolization: an analysis of ten cases.
    Dou JP; Yu J; Han ZY; Liu FY; Cheng ZG; Liang P
    Abdom Radiol (NY); 2017 Mar; 42(3):962-968. PubMed ID: 27688061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined Transarterial Chemoembolization with Microwave Ablation
    El-Agawy W; El-Ganainy SA; Gad MAA; Abd-Elsalam S; Mostafa WAA; El-Shewi ME
    Curr Cancer Drug Targets; 2022; 22(1):77-85. PubMed ID: 35078397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.